127 related articles for article (PubMed ID: 15904876)
21. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles.
Christoffersen C; Benn M; Christensen PM; Gordts PLSM; Roebroek AJM; Frikke-Schmidt R; Tybjaerg-Hansen A; Dahlbäck B; Nielsen LB
J Lipid Res; 2012 Oct; 53(10):2198-2204. PubMed ID: 22826357
[TBL] [Abstract][Full Text] [Related]
22. Resveratrol exerts a biphasic effect on apolipoprotein M.
Kurano M; Hara M; Nojiri T; Ikeda H; Tsukamoto K; Yatomi Y
Br J Pharmacol; 2016 Jan; 173(1):222-33. PubMed ID: 26445217
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
[TBL] [Abstract][Full Text] [Related]
24. The signal peptide anchors apolipoprotein M in plasma lipoproteins and prevents rapid clearance of apolipoprotein M from plasma.
Christoffersen C; Ahnström J; Axler O; Christensen EI; Dahlbäck B; Nielsen LB
J Biol Chem; 2008 Jul; 283(27):18765-72. PubMed ID: 18460466
[TBL] [Abstract][Full Text] [Related]
25. The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis.
Hu YW; Chen ZP; Hu XM; Zhao JY; Huang JL; Ma X; Li SF; Qiu YR; Wu XJ; Sha YH; Gao JJ; Wang YC; Zheng L; Wang Q
Apoptosis; 2015 Oct; 20(10):1321-37. PubMed ID: 26201458
[TBL] [Abstract][Full Text] [Related]
26. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
[TBL] [Abstract][Full Text] [Related]
27. Effects of simvastatin on apolipoprotein M in vivo and in vitro.
Zhang X; Mao S; Luo G; Wei J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Jul; 10():112. PubMed ID: 21729290
[TBL] [Abstract][Full Text] [Related]
28. Expression pattern of apolipoprotein M during mouse and human embryogenesis.
Zhang XY; Jiao GQ; Hurtig M; Dong X; Zheng L; Luo GH; Nilsson-Ehle P; Ye Q; Xu N
Acta Histochem; 2004; 106(2):123-8. PubMed ID: 15147633
[TBL] [Abstract][Full Text] [Related]
29. Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects.
Xu N; Nilsson-Ehle P; Ahrén B
J Nutr Biochem; 2004 Oct; 15(10):579-82. PubMed ID: 15542348
[TBL] [Abstract][Full Text] [Related]
30. Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases.
Jiang J; Zhang X; Wu C; Qin X; Luo G; Deng H; Lu M; Xu B; Li M; Ji M; Xu N
Lipids Health Dis; 2008 Jul; 7():25. PubMed ID: 18652652
[TBL] [Abstract][Full Text] [Related]
31. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
Xu N; Nilsson-Ehle P; Ahrén B
Biochem Biophys Res Commun; 2006 Apr; 342(4):1174-7. PubMed ID: 16516154
[TBL] [Abstract][Full Text] [Related]
32. Expression of apolipoprotein M in human hepatocellular carcinoma tissues.
Jiang J; Wu C; Luo G; Zheng L; Chen L; Zhang X; Xu N
Acta Histochem; 2011 Jan; 113(1):53-7. PubMed ID: 19796793
[TBL] [Abstract][Full Text] [Related]
33. HDL stimulates apoM secretion.
Ahnström J; Axler O; Dahlbäck B
Protein Pept Lett; 2010 Oct; 17(10):1285-9. PubMed ID: 20518736
[TBL] [Abstract][Full Text] [Related]
34. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M.
Faber K; Hvidberg V; Moestrup SK; Dahlbäck B; Nielsen LB
Mol Endocrinol; 2006 Jan; 20(1):212-8. PubMed ID: 16099815
[TBL] [Abstract][Full Text] [Related]
35. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
36. A novel human apolipoprotein (apoM).
Xu N; Dahlbäck B
J Biol Chem; 1999 Oct; 274(44):31286-90. PubMed ID: 10531326
[TBL] [Abstract][Full Text] [Related]
37. Atorvastatin upregulates apolipoprotein M expression via attenuating LXRα expression in hyperlipidemic apoE-deficient mice.
Liu J; Huang H; Shi S; Wang X; Yu Y; Hu Y; Sun J; Ren C; Yang J; Shen Z
Exp Ther Med; 2018 Nov; 16(5):3785-3792. PubMed ID: 30344653
[TBL] [Abstract][Full Text] [Related]
38. Effect of cell cholesterol content on apolipoprotein B secretion and LDL receptor activity in the human hepatoma cell line, HepG2.
Fuki IV; Preobrazhensky SN; Misharin AYu ; Bushmakina NG; Menschikov GB; Repin VS; Karpov RS
Biochim Biophys Acta; 1989 Feb; 1001(2):235-8. PubMed ID: 2537098
[TBL] [Abstract][Full Text] [Related]
39. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization.
Zhang XY; Dong X; Zheng L; Luo GH; Liu YH; Ekström U; Nilsson-Ehle P; Ye Q; Xu N
Acta Histochem; 2003; 105(1):67-72. PubMed ID: 12666989
[TBL] [Abstract][Full Text] [Related]
40. Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXRα expression in HepG2 cells.
Zhao JY; Hu YW; Li SF; Hu YR; Ma X; Wu SG; Wang YC; Gao JJ; Sha YH; Zheng L; Wang Q
Lipids Health Dis; 2014 Mar; 13():50. PubMed ID: 24642298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
